In recent trading session, Sana Biotechnology Inc (NASDAQ:SANA) saw 1.27 million shares changing hands at last check today with its beta currently measuring 1.78. Company’s recent per share price level of $1.43 trading at -$0.2 or -12.15% at last check today assigns it a market valuation of $322.21M. That most recent trading price of SANA’s stock is at a discount of -634.27% from its 52-week high price of $10.50 and is indicating a discount of -3.5% from its 52-week low price of $1.48. Taking a look at company’s average trading volume for last 10-days demonstrates a volume of 3.89 million shares which gives us an average trading volume of 7.69 million if we extend that period to 3-months.
For Sana Biotechnology Inc (SANA), analysts’ consensus is at an average recommendation of Buy while assigning it a mean rating of 1.00. Splitting up the data highlights that, out of 2 analysts covering the stock, 0 rated the stock as a Sell while 0 recommended an Overweight rating for the stock. 0 suggested the stock as a Hold whereas 2 see the stock as a Buy. 0 analyst(s) advised it as an Underweight. The company is expected to be making an EPS of -0.2 in the current quarter.
Sana Biotechnology Inc (NASDAQ:SANA) trade information
Upright in the red during last session for losing -12.15%, in the last five days SANA remained trading in the red while hitting it’s week-highest on Friday, 03/28/25 when the stock touched $1.43 price level, adding 22.28% to its value on the day. Sana Biotechnology Inc’s shares saw a change of -12.15% in year-to-date performance and have moved -22.39% in past 5-day. Sana Biotechnology Inc (NASDAQ:SANA) showed a performance of -43.85% in past 30-days. Number of shares sold short was 39.89 million shares which calculate 14.72 days to cover the short interests.
Wall Street analysts have assigned a consensus price target of 8 to the stock, which implies a rise of 82.12% to its recent value today. Analysts have been projecting 8 as a low price target for the stock while placing it at a high target of 8. It follows that stock’s current price would drop -459.44% in reaching the projected high whereas dropping to the targeted low would mean a loss of -459.44% for stock’s current value.
Sana Biotechnology Inc (SANA) estimates and forecasts
Weighing up company’s earnings over the past 5-year and in the next 5-year periods, we find the company posting an annual earnings growth rate of -10.60% during past 5 years. In 2025, company’s earnings growth rate is likely to be around 20.37% while estimates for its earnings growth in next 5 years are of 3.95%.
Sana Biotechnology Inc (NASDAQ:SANA)’s Major holders
Insiders are in possession of 8.58% of company’s total shares while institution are holding 93.70 percent of that, with stock having share float percentage of 102.50%. Investors also watch the number of corporate investors in a company very closely, which is 93.70% institutions for Sana Biotechnology Inc that are currently holding shares of the company. FMR LLC is the top institutional holder at SANA for having 27.17 million shares of worth $148.35 million. And as of 2024-06-30, it was holding 11.5894 of the company’s outstanding shares.
The second largest institutional holder is FLAGSHIP PIONEERING INC., which was holding about 25.0 million shares on 2024-06-30. The number of shares represents firm’s hold over 10.6645 of outstanding shares, having a total worth of $136.51 million.
On the other hand, Fidelity Mt. Vernon Street Trust-Fidelity Growth Company Fund and SMALLCAP WORLD FUND INC are the top two Mutual Funds which own company’s shares. As of Feb 28, 2025, the former fund manager was holding 9.6 shares of worth $13.77 million or 4.27% of the total outstanding shares. The later fund manager was in possession of 5.88 shares on Dec 31, 2024, making its stake of worth around $8.44 million in the company or a holder of 2.61% of company’s stock.
